Precision BioSciences, Inc. Made Big Gain
Wed, Nov 01, 2023 at 07:39 PM
Precision BioSciences, Inc. (DTIL:NASDAQ) shot up at $0.4, representing a gain of 29.6%. On Wed, Nov 01, 2023, DTIL:NASDAQ touched a New 2-Week High of $0.4. The stock got featured on our News Catalysts scanner on Wed, Nov 01, 2023 at 10:03 AM in the 'EARNINGS' category. From Wed, Oct 18, 2023, the stock recorded 30.00% Up Days and 27.27% Green Days
About Precision BioSciences, Inc. (DTIL:NASDAQ)
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The company's segments include Therapeutics and Food.
Top 10 Gainers:
- Cellectis S.A. (CLLS:NASDAQ), 173.86%
- Patriot Transportation Holding, Inc. (PATI:NASDAQ), 103.13%
- Aldeyra Therapeutics, Inc. (ALDX:NASDAQ), 48.54%
- Sientra, Inc. (SIEN:NASDAQ), 32.95%
- Impel NeuroPharma Inc. (IMPL:NASDAQ), 31.45%
- PMV Pharmaceuticals Inc. (PMVP:NASDAQ), 31.13%
- TG Therapeutics, Inc. (TGTX:NASDAQ), 30.92%
- Local Bounti Corporation (LOCL:NYSE), 30.12%
- Precision BioSciences, Inc. (DTIL:NASDAQ), 29.63%
- Silence Therapeutics Plc (SLN:NASDAQ), 29.25%